| Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ... World Psychiatry 15 (2), 166-174, 2016 | 727 | 2016 |
| Antipsychotic medication in schizophrenia: a review J Lally, JH MacCabe British medical bulletin 114 (1), 169-179, 2015 | 647 | 2015 |
| Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies J Lally, O Ajnakina, B Stubbs, M Cullinane, KC Murphy, F Gaughran, ... The British Journal of Psychiatry 211 (6), 350-358, 2017 | 377 | 2017 |
| Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ... Psychological medicine 46 (15), 3231-3240, 2016 | 316 | 2016 |
| Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis J Lally, J Tully, D Robertson, B Stubbs, F Gaughran, JH MacCabe Schizophrenia research 171 (1-3), 215-224, 2016 | 187 | 2016 |
| Stigma of mental illness and help-seeking intention in university students J Lally, A ó Conghaile, S Quigley, E Bainbridge, C McDonald The Psychiatrist 37 (8), 253-260, 2013 | 187 | 2013 |
| Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial P Gardner-Sood, J Lally, S Smith, Z Atakan, K Ismail, KE Greenwood, ... Psychological medicine 45 (12), 2619-2629, 2015 | 181 | 2015 |
| Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low-and middle-income countries B Stubbs, A Koyanagi, N Veronese, D Vancampfort, M Solmi, F Gaughran, ... BMC medicine 14, 1-12, 2016 | 167 | 2016 |
| Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics J Lally, F Gaughran, P Timms, SR Curran Pharmacogenomics and personalized medicine, 117-129, 2016 | 166 | 2016 |
| Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis A Shirazi, B Stubbs, L Gomez, S Moore, F Gaughran, RJ Flanagan, ... International Journal of Molecular Sciences 17 (6), 863, 2016 | 141 | 2016 |
| Vitamin D deficiency in first episode psychosis: a case–control study M Crews, J Lally, P Gardner-Sood, O Howes, S Bonaccorso, S Smith, ... Schizophrenia research 150 (2-3), 533-537, 2013 | 129 | 2013 |
| Mental health services in the Philippines J Lally, J Tully, R Samaniego BJPsych international 16 (3), 62-64, 2019 | 125 | 2019 |
| Uncertainty and ambiguity and their association with psychological distress in medical students J Lally, P Cantillon Academic Psychiatry 38, 339-344, 2014 | 105 | 2014 |
| Substance use, medication adherence and outcome one year following a first episode of psychosis M Colizzi, E Carra, S Fraietta, J Lally, D Quattrone, S Bonaccorso, ... Schizophrenia research 170 (2-3), 311-317, 2016 | 90 | 2016 |
| Clinical correlates of vitamin D deficiency in established psychosis J Lally, P Gardner-Sood, M Firdosi, C Iyegbe, B Stubbs, K Greenwood, ... BMC psychiatry 16, 1-9, 2016 | 76 | 2016 |
| Mental health legislation in the Philippines: Philippine mental health act J Lally, RM Samaniego, J Tully BJPsych international 16 (3), 65-67, 2019 | 69 | 2019 |
| Treatment resistant schizophrenia–review and a call to action J Lally, F Gaughran Irish journal of psychological medicine 36 (4), 279-291, 2019 | 64 | 2019 |
| Changes in brain glutamate on switching to clozapine in treatment-resistant schizophrenia G McQueen, KV Sendt, A Gillespie, A Avila, J Lally, K Vallianatou, ... Schizophrenia bulletin 47 (3), 662-671, 2021 | 57 | 2021 |
| Mental disorders in Malaysia: an increase in lifetime prevalence S Raaj, S Navanathan, M Tharmaselan, J Lally BJPsych international 18 (4), 97-99, 2021 | 51 | 2021 |
| Increases in triglyceride levels are associated with clinical response to clozapine treatment J Lally, A Gallagher, E Bainbridge, G Avalos, M Ahmed, C McDonald Journal of Psychopharmacology 27 (4), 401-403, 2013 | 51 | 2013 |
James MacCabeProfessor of Epidemiology and Therapeutics in Psychosis, Institute of Psychiatry, Psychology andBestätigte E-Mail-Adresse bei kcl.ac.uk
